SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
| | | |
| Date of Report (Date of earliest event reported): | | February 24, 2004 |
United Therapeutics Corporation
(Exact Name of Registrant as Specified in Charter)
| | | | | |
| Delaware | | 000-26301 | | 52-1984749 |
| |
| |
|
(State or Other
Jurisdiction of
Incorporation) | | (Commission
File Number) | | (I.R.S. Employer
Identification Number) |
| | | |
1110 Spring Street
Silver Spring, MD | | 20910 |
| |
|
| (Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s telephone number, including area code:
(301) 608-9292
Item 12. Earnings Announcements or Releases.
On February 24, 2004, United Therapeutics Corporation (the “Company”) issued a press release setting forth its earnings for the Company’s quarterly fiscal period and year ended December 31, 2003. A copy of this press release is attached hereto as Exhibit 99.1. The Company does not intend for Exhibit 99.1 to be incorporated by reference into filings under the Securities Act of 1933 or the Securities Exchange Act of 1934.
Item 7. Exhibits
(c) Exhibits
| | | |
| Exhibit No. | | Description of Exhibit |
| |
|
| 99.1 | | Press release dated February 24, 2004 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | | |
| | UNITED THERAPEUTICS CORPORATION | | |
| | | | | | | |
| Dated: February 24, 2004 | | By:
Name:
Title: | | /s/ Paul A. Mahon
Paul A. Mahon
General Counsel | | |
EXHIBIT INDEX
| | | |
| Exhibit No. | | Description of Exhibit |
| |
|
| 99.1 | | Press release dated February 24, 2004 |
